Development of leptomeningeal carcinomatosis during a marked response of brain metastases to pembrolizumab in a patient with non-small-cell lung cancer

被引：6
|
作者：
Otsubo, K. [1 ,2 ]
Seki, N. [1 ,2 ]
Nakanishi, Y. [1 ,2 ]
Okamoto, I. [1 ,2 ]
机构：
[1] Kyushu Univ, Chest Dis Res Inst, Grad Sch Med Sci, Fukuoka, Japan
[2] Kyushu Univ, Chest Dis Res Inst, Grad Sch Med Sci, Fukuoka, Japan
来源：
ANNALS OF ONCOLOGY | 2018年 / 29卷 / 03期
关键词：
D O I：
10.1093/annonc/mdx700
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：780 / 781
页数：2
相关论文
共 50 条
  • [21] ANALYSIS OF 105 PATIENTS WITH INTRAVENTRICULAR CHEMOTHERAPY FOR LEPTOMENINGEAL CARCINOMATOSIS FROM NON-SMALL-CELL LUNG CANCER
    Gwak, Ho-Shin
    Joo, Jungnam
    Kim, Sohee
    Yoo, Heon
    Shin, Sang Hoon
    Han, Ji-Youn
    Kim, Heung Tae
    Yun, Tak
    Lee, Jin Soo
    Lee, Seung Hoon
    Kim, Woojun
    NEURO-ONCOLOGY, 2012, 14 : 75 - 75
  • [22] Histologic transformation of non-small-cell lung cancer in brain metastases
    Jiang, Meng
    Zhu, Xiaolong
    Han, Xiao
    Jing, Haiyan
    Han, Tao
    Li, Qiang
    Ding, Xiao
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2019, 24 (04) : 375 - 384
  • [23] Histologic transformation of non-small-cell lung cancer in brain metastases
    Meng Jiang
    Xiaolong Zhu
    Xiao Han
    Haiyan Jing
    Tao Han
    Qiang Li
    Xiao Ding
    International Journal of Clinical Oncology, 2019, 24 : 375 - 384
  • [24] Cystic Brain Metastases Revealed Patient With RET-Rearranged Non?Small-Cell Lung Cancer With Leptomeningeal Carcinomatosis and RET-Positive in CSF
    Remon, Jordi
    Esteller, Laura
    Teresa Rodrigo, Maria
    Martin, Raquel
    Ramirez, David
    Vives, Josep
    Conde, Esther
    Hernandez, Susana
    JCO PRECISION ONCOLOGY, 2020, 4 : 1 - 5
  • [25] Follicular psoriasis induced by pembrolizumab in a patient with advanced non-small-cell lung cancer
    Scarfi, Federica
    Lacava, Rossella
    Patrizi, Annalisa
    Tartari, Federico
    Ravaioli, Giulia Maria
    Veronesi, Giulia
    Lambertini, Martina
    Dika, Emi
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2019, 58 (08) : E151 - E152
  • [26] Four-Year Lasting Sustained Complete Response After Nivolumab in a Patient With Non-Small-Cell Lung Cancer and Confirmed Leptomeningeal Carcinomatosis: Changing the Paradigm
    Bover, Mateo
    Yarza, Ramon
    Iglesias Docampo, Lara
    CLINICAL LUNG CANCER, 2020, 21 (01) : E1 - E5
  • [27] Remarkable response to dacomitinib in a patient with leptomeningeal carcinomatosis due to EGFR-mutant non-small cell lung cancer
    Mizusaki, Shun
    Otsubo, Kohei
    Ninomiya, Toshifumi
    Arimura, Hidenobu
    Tsuchiya-Kawano, Yuko
    Inoue, Koji
    THORACIC CANCER, 2021, 12 (01) : 114 - 116
  • [28] Treatment options for brain metastases in patients with non-small-cell lung cancer
    Sadaf Taimur
    Martin J. Edelman
    Current Oncology Reports, 2003, 5 (4) : 342 - 346
  • [29] Risk factors for brain metastases in patients with non-small-cell lung cancer
    An, Ning
    Jing, Wang
    Wang, Haoyi
    Li, Ji
    Liu, Yang
    Yu, Jinming
    Zhu, Hui
    CANCER MEDICINE, 2018, 7 (12): : 6357 - 6364
  • [30] Immune Checkpoint Inhibitors for Brain Metastases of Non-Small-Cell Lung Cancer
    Ashinuma, H.
    Shingyoji, M.
    Iuchi, T.
    Yoshida, Y.
    Setoguchi, T.
    Hasegawa, Y.
    Sakaida, T.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2420 - S2420
12345